Technology
A 20-year-old cancer vaccine may hold the key to long-term survival
2026-01-30 01:13
371 views
Two decades after a breast cancer vaccine trial, every participant is still alive—an astonishing result for metastatic disease. Scientists found their immune systems retained long-lasting memory cells...
Two decades after a breast cancer vaccine trial, every participant is still alive—an astonishing result for metastatic disease. Scientists found their immune systems retained long-lasting memory cells primed to recognize cancer. By enhancing a key immune signal called CD27, researchers dramatically improved tumor elimination in lab studies. The findings suggest cancer vaccines may have been missing a crucial ingredient all along.
Related Articles
Ryan Reynolds and Kenneth Branagh are unlikely allies in first look at "genre-bending, action packed buddy comedy" from Dungeons and Dragons directors
509 views
Doom devs including John Romero respond to terminally ill fan spending his final days playing Doom: The Dark Ages: "You are not alone in that hospital room"
872 views
Today’s Wordle answer and hints for #1691 on February 04
790 views